Predicted to enable identical protein binding activity. Predicted to be involved in several processes, including intracellular triglyceride homeostasis; negative regulation of non-canonical NF-kappaB signal transduction; and regulation of cytokine production. Predicted to act upstream of or within glucose homeostasis; negative regulation of gluconeogenesis; and positive regulation of intracellular signal transduction. Predicted to be located in extracellular space. Predicted to be part of protein-containing complex. Orthologous to human C1QTNF3 (C1q and TNF related 3).
RGD Description
Predicted to enable identical protein binding activity. Predicted to be involved in several processes, including intracellular triglyceride homeostasis; negative regulation of non-canonical NF-kappaB signal transduction; and regulation of cytokine production. Predicted to act upstream of or within glucose homeostasis; negative regulation of gluconeogenesis; and positive regulation of intracellular signal transduction. Predicted to be located in extracellular region. Predicted to be part of protein-containing complex. Predicted to be active in extracellular space. Orthologous to human C1QTNF3 (C1q and TNF related 3); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; 6-propyl-2-thiouracil.